HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects

被引：0

作者：

Catherine Butkus Small

David A. Margolis

Mark S. Shaefer

Lisa L. Ross

机构：

[1] Weill Cornell Medical College,

[2] New York Medical College,undefined

[3] ViiV Healthcare,undefined

来源：

BMC Infectious Diseases | / 17卷

关键词：

Abacavir; Lamivudine; Hypersensitivity; HLA-B*57:01; HIV infection;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects
Small, Catherine Butkus
Margolis, David A.
Shaefer, Mark S.
Ross, Lisa L.
BMC INFECTIOUS DISEASES, 2017, 17
[2] FREQUENCY OF HLA-B*57:01 ALLELE IN HIV-INFECTED PATIENTS AND SCREENING FOR ABACAVIR THERAPY
Giuliodori, Silvia
Lamanna, Roberta
Benecchi, Magda
Zanelli, Paola
HLA, 2017, 89 (06) : 471 - 472
[3] The First Case of Abacavir Hypersensitivity Associated with the HLA-B*57:01-Positive Allele in Korea
Yoon, Ji Hyun
Kim, Mingoo
Jin, Sung Joon
Kim, Seung Kyu
Lee, Seo Hui
Cheon, Jaeyoung
Yun, Gi Young
Kim, Min Kyung
Ha, Jiyoon
Song, Young Goo
INFECTION AND CHEMOTHERAPY, 2012, 44 (05): : 399 - 402
[4] Prevalence of HLA-B*57:01 allele in Argentinean HIV-1 infected patients
Moragas, M.
Belloso, W. H.
Baquedano, M. S.
Gutierrez, M. I.
Bissio, E.
Larriba, J. M.
Fay, F.
Aulicino, P.
Gurevich, J. M.
Yaunguzian, M. F.
Maldonado, A. C.
Falistocco, C.
Sen, L.
Mangano, A.
TISSUE ANTIGENS, 2015, 86 (01): : 28 - 31
[5] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY IN NORTH INDIANS
Kanga, Uma
Sharma, Gaurav
Sharma, Akanksha
Alwadhi, Ajeet
Abid, Mohd
Gautam, Sashi K.
HUMAN IMMUNOLOGY, 2019, 80 : 106 - 106
[6] PREVALENCE OF HUMAN LEUKOCYTE ANTIGEN HLA-B☆57:01 IN HIV-INFECTED SUBJECTS IN THE CZECH REPUBLIC
Jilich, David
Vrana, Milena
Snopkova, Svatava
Sedlacek, Dalibor
Kapla, Jaroslav
Rozsypal, Hanus
Kolcakova, Jitka
Olbrechtova, Lenka
Zjevikova, Alena
Jerhotova, Zdenka
Maly, Marek
Stankova, Marie
Machala, Ladislav
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2011, 19 (03) : 128 - 130
[7] HLA-B*57:01 allele prevalence in treatment-Naive HIV-infected patients from Colombia
Martinez Buitrago, Ernesto
Millan Onate, Jose
Fernando Garcia-Goez, Jose
Alvarez, Jorge
Lenis, William
Marina Sanudo, Luz
Consuelo Rubiano, Luisa
BMC INFECTIOUS DISEASES, 2019, 19 (01)
[8] Prevalence of abacavir-associated hypersensitivity syndrome and HLA-B*5701 allele in a Portuguese HIV population
Santos, N.
Pinheiro, C.
Carolino, F.
Faustino, A. S.
Soares, P.
Sarmento, A.
Rodrigues Cernadas, J.
ALLERGY, 2013, 68 : 517 - 518
[9] HLA-B*57:01 ALLELE RESEARCH IN HIV PATIENTS FOR ABACAVIR TREATMENT: A SINGLE CENTER EXPERIENCE
Cappuzzo, Valentina
Ingrassia, Francesco
Blando, Maria
Vega, Igea
Bavetta, Rosalba
Collura, Emanuela
Mistretta, Serena
Marceno, Raimondo
TISSUE ANTIGENS, 2014, 84 (01): : 155 - 156
[10] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY AMONG NORTH INDIANS
Kanga, Uma
Sharma, Akanksha
Alwadhi, Ajit
Kapoor, Shashi
Abid, Mohd.
HLA, 2020, 95 (04) : 356 - 357

← 1 2 3 4 5 →

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjects

HLA-B57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B57:01-negative subjects